Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
21%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
WDNA
85
HOLDINGS
18%
ALSO IN CANC
CANC
52
HOLDINGS
29%
ALSO IN WDNA
SECTOR DRIFT (WDNA minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 4.0% | 4.4% | 4.0% |
|
ELI LILLY & CO | 2.3% | 5.8% | 2.3% |
 |
NOVARTIS AG | 1.9% | 4.0% | 1.9% |
|
GILEAD SCIENCES INC | 1.9% | 2.2% | 1.9% |
|
JOHNSON & JOHNSON | 1.5% | 2.2% | 1.5% |
WDNA Overweight Relative to CANC
|
NATERA INC | 4.4% |
|
BLUEPRINT MEDICINES CORP. | 3.8% |
 |
NOVOZYMES A/S-B SHARES | 3.2% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% |
|
STOKE THERAPEUTICS, INC. | 2.3% |
|
TWIST BIOSCIENCE CORP. | 2.2% |
|
UNITED THERAPEUTICS CORP | 2.2% |
|
AGIOS PHARMACEUTICALS INC | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.1% |
|
VERACYTE INC | 2.1% |
WDNA Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.4% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
 |
ASTRAZENECA PLC | -4.0% |
|
NUVALENT, INC. CLASS A | -3.6% |
|
ELI LILLY & CO | -3.5% |
|
EXELIXIS INC | -3.1% |
|
ARCELLX, INC. | -3.0% |
|
ABBVIE INC | -2.7% |
|
IDEAYA BIOSCIENCES, INC. | -2.6% |
|
GENMAB A/S SPONSORED ADR | -2.6% |